October 19, 2004
Researchers at Pharmaceutica claim to have discovered a compound that renders the MRSA superbug vulnerable to the antibiotic it normally resists.
MRSA — methicillin-resistant Staphylococcus aureus — is defined by its ability to resist the antibiotic methicillin. MRSA strains now cause up to 60% of all “staph” infections in some hospitals. Some MRSA strains are also becoming resistant to other antibiotics — including vancomycin, the antibiotic doctors resort to… read more